• |
  • |
  • |
  • |
Donate

Product

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma; a Childrens Oncology Group report.

Center:
Fiscal Year:
2013
Contact Information:
Product Description:
Keyword(s):
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
URL
COVID-19 Related Data:
N/A